EquityZen Growth Technology Fund LLC - Series 1935
Raised
$810K
Investors
24
Min Invest
$4,968
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1935 is a Delaware-based pooled investment fund filed by EquityZen Advisors LLC and Philip Haslett on July 19, 2024. The entity raised $810,000 from 24 investors under Rule 506(b) and Section 3(c)(1) exemptions, with a $5,000 minimum investment. This is part of EquityZen's private equity platform, which has filed over 150 related series vehicles.
This filing represents a typical private equity SPV structure operating under 506(b) and 3(c)(1) exemptions, limiting it to 99 beneficial owners and accredited investors. The $5,000 minimum investment is at the lower end of the spectrum for private equity access, consistent with EquityZen's platform model of democratizing access to pre-IPO equity through serialized fund structures.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
